Genzyme, which makes drugs to treat leukemia and multiple sclerosis, has rejected a hostile takeover bid from French drugmaker Sanofi-Aventis. The offer “dramatically undervalues” Genzyme, the company said Friday, putting its value about 30% higher.
Continue reading Genzyme Rejects Sanofi-Aventis Takeover Bid
Genzyme Rejects Sanofi-Aventis Takeover Bid originally appeared on DailyFinance on Fri, 22 Oct 2010 19:30:00.
Filed Under: Company News, Technology, Health Care, Genzyme Corporation , Sanofi Aventis